Jiangxi Fushine Pharmaceutical Co., Ltd. announced a private placement of A shares for gross proceeds of not more than CNY 300,000,000 on December 4, 2023. The transaction will include participation from not more than 35 investors. The shares cannot be transferred within 6 months from the issuance closing date.

The transaction has been approved at the 16th meeting of the 4th directorate and the 11th meeting of the 4th supervisory board of the company. The transaction still needs to be approved by the company?s directorate, the Shenzhen Stock Exchange and the China Securities Regulatory Commission.